Get started
Author

Yoshitaka Minamida

ORCID: 0000-0002-6683-8282
Observed ORCID: 0000-0002-6683-8282
OpenAlex ID: A5014427933
Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell–mediated remissions
2018 · Suparna Dutt, Michelle B. Atallah, et al. · Blood Advances · 20
PDF
Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al. · Cancer Research Communications · 19
PDF
FLASH/casp8ap2 Is Indispensable for Early Embryogenesis but Dispensable for Proliferation and Differentiation of ES Cells
2014 · Yoshitaka Minamida, Masataka Someda, et al. · PLoS ONE · 9
PDF
Abstract 519: Identification of a novel target for antibody therapy of breast cancer
2012 · Fumiyoshi Okano, Takanori Saito, et al. · Cancer Research · 1
Abstract 5407: Mechanism of CAPRIN-1 membrane localization in cancer and development of TRK-950, a humanized anti-CAPRIN-1 antibody.
2026 · Yoshitaka Minamida, Shoichi Ohno, et al. · Cancer Research
Figure S7 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Figure S9 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Figure S4 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
PDF
Figure S2 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
PDF
Figure S5 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
PDF
Table S2 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
PDF
Figure S8 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Figure S6 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
PDF
Data from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Figure S4 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Table S1 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Figure S6 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Figure S8 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
PDF
Figure S9 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
PDF
Figure S3 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Figure S1 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
PDF
Figure S5 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Table S2 from Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al.
Abstract 3923: Identification of membrane-expressed CAPRIN-1 as a novel and universal cancer target and generation of a therapeutic anti-CAPRIN-1 antibody TRK-950
2023 · Fumiyoshi Okano, Takanori Saito, et al. · Cancer Research
Works count: 24
Citation count: 49
H-index: 3
I10-index: 2
Year
Topic
Type